Convalescent plasma: Alternative or promising therapy?

Highlights • Convalescent plasma (CP) may be a suitable specific therapy for COVID-19. • CP therapy is safe and effective in COVID-19 patients. • Neutralising antibodies in CP help to control SARS-CoV-2 infection and modulate the inflammatory response. • Plasma components may enhance the antiviral and anti-inflammatory properties of CP. • CP therapy seems healthy, clinically successful and decreases mortality in COVID-19 patients.